{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:51:06Z","timestamp":1790358666826,"version":"4.1.0"},"reference-count":101,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T00:00:00Z","timestamp":1588032000000},"content-version":"vor","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2017R1A2B3002989"],"award-info":[{"award-number":["2017R1A2B3002989"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2017R1A2B3002989"],"award-info":[{"award-number":["2017R1A2B3002989"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Mol Med"],"published-print":{"date-parts":[[2020,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Recently, with the development of RNA sequencing technologies such as next-generation sequencing (NGS) for RNA, numerous variations of alternatively processed RNAs made by alternative splicing, RNA editing, alternative maturation of microRNA (miRNA), RNA methylation, and alternative polyadenylation have been uncovered. Furthermore, abnormally processed RNAs can cause a variety of diseases, including obesity, diabetes, Alzheimer\u2019s disease, and cancer. Especially in cancer development, aberrant RNAs caused by deregulated RNA modifiers or regulators are related to progression. Accumulating evidence has reported that aberrant RNAs promote carcinogenesis in many cancers, including liver cancer, leukemia, melanoma, lung cancer, breast cancer, and other cancers, in which abnormal RNA processing occurs in normal cells. Therefore, it is necessary to understand the precise roles and mechanisms of disease-related RNA processing in various cancers for the development of therapeutic interventions. In this review, the underlying mechanisms of variations in the RNA life cycle and the biological impacts of RNA variations on carcinogenesis will be discussed, and therapeutic strategies for the treatment of tumor malignancies will be provided. We also discuss emerging roles of RNA regulators in hepatocellular carcinogenesis.<\/jats:p>","DOI":"10.1038\/s12276-020-0429-6","type":"journal-article","created":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T08:02:46Z","timestamp":1588060966000},"page":"582-593","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Pathogenic diversity of RNA variants and RNA variation-associated factors in cancer development"],"prefix":"10.1038","volume":"52","author":[{"given":"Hee Doo","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suk Woo","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,28]]},"reference":[{"key":"429_CR1","doi-asserted-by":"crossref","unstructured":"Flavahan, W. A., Gaskell, E. & Bernstein, B. E. Epigenetic plasticity and the hallmarks of cancer. Science 357, eaal2380 (2017).","DOI":"10.1126\/science.aal2380"},{"key":"429_CR2","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1158\/2159-8290.CD-19-0399","volume":"9","author":"EA Obeng","year":"2019","unstructured":"Obeng, E. A., Stewart, C. & Abdel-Wahab, O. Altered RNA processing in cancer pathogenesis and therapy. Cancer Discov. 9, 1493\u20131510 (2019).","journal-title":"Cancer Discov."},{"key":"429_CR3","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1038\/ng.3414","volume":"47","author":"H Jung","year":"2015","unstructured":"Jung, H. et al. Intron retention is a widespread mechanism of tumor-suppressor inactivation. Nat. Genet. 47, 1242\u20131248 (2015).","journal-title":"Nat. Genet."},{"key":"429_CR4","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/nrm3611","volume":"14","author":"SL Ameres","year":"2013","unstructured":"Ameres, S. L. & Zamore, P. D. Diversifying microRNA sequence and function. Nat. Rev. Mol. Cell Biol. 14, 475\u2013488 (2013).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"429_CR5","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature11247","volume":"489","author":"EP Consortium","year":"2012","unstructured":"Consortium, E. P. An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57\u201374 (2012).","journal-title":"Nature"},{"key":"429_CR6","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1146\/annurev-biochem-060614-034316","volume":"84","author":"Y Lee","year":"2015","unstructured":"Lee, Y. & Rio, D. C. Mechanisms and regulation of alternative Pre-mRNA splicing. Annu. Rev. Biochem. 84, 291\u2013323 (2015).","journal-title":"Annu. Rev. Biochem."},{"key":"429_CR7","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/nsmb.2207","volume":"19","author":"O Anczukow","year":"2012","unstructured":"Anczukow, O. et al. The splicing factor SRSF1 regulates apoptosis and proliferation to promote mammary epithelial cell transformation. Nat. Struct. Mol. Biol. 19, 220\u2013228 (2012).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"429_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10615","volume":"7","author":"S Alsafadi","year":"2016","unstructured":"Alsafadi, S. et al. Cancer-associated SF3B1 mutations affect alternative splicing by promoting alternative branchpoint usage. Nat. Commun. 7, 10615 (2016).","journal-title":"Nat. Commun."},{"key":"429_CR9","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/nature07509","volume":"456","author":"ET Wang","year":"2008","unstructured":"Wang, E. T. et al. Alternative isoform regulation in human tissue transcriptomes. Nature 456, 470\u2013476 (2008).","journal-title":"Nature"},{"key":"429_CR10","doi-asserted-by":"publisher","first-page":"11093","DOI":"10.1073\/pnas.1101135108","volume":"108","author":"KH Lim","year":"2011","unstructured":"Lim, K. H., Ferraris, L., Filloux, M. E., Raphael, B. J. & Fairbrother, W. G. Using positional distribution to identify splicing elements and predict pre-mRNA processing defects in human genes. Proc. Natl Acad. Sci. USA 108, 11093\u201311098 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"429_CR11","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.ceb.2005.04.014","volume":"17","author":"AR Kornblihtt","year":"2005","unstructured":"Kornblihtt, A. R. Promoter usage and alternative splicing. Curr. Opin. Cell Biol. 17, 262\u2013268 (2005).","journal-title":"Curr. Opin. Cell Biol."},{"key":"429_CR12","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1126\/science.1184208","volume":"327","author":"RF Luco","year":"2010","unstructured":"Luco, R. F. et al. Regulation of alternative splicing by histone modifications. Science 327, 996\u20131000 (2010).","journal-title":"Science"},{"key":"429_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1002717","volume":"8","author":"MM Pradeepa","year":"2012","unstructured":"Pradeepa, M. M., Sutherland, H. G., Ule, J., Grimes, G. R. & Bickmore, W. A. Psip1\/Ledgf p52 binds methylated histone H3K36 and splicing factors and contributes to the regulation of alternative splicing. PLoS Genet. 8, e1002717 (2012).","journal-title":"PLoS Genet."},{"key":"429_CR14","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/0092-8674(87)90239-X","volume":"48","author":"BL Bass","year":"1987","unstructured":"Bass, B. L. & Weintraub, H. A developmentally regulated activity that unwinds RNA duplexes. Cell 48, 607\u2013613 (1987).","journal-title":"Cell"},{"key":"429_CR15","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/379460a0","volume":"379","author":"T Melcher","year":"1996","unstructured":"Melcher, T. et al. A mammalian RNA editing enzyme. Nature 379, 460\u2013464 (1996).","journal-title":"Nature"},{"key":"429_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-019-2071-4","volume":"17","author":"T Christofi","year":"2019","unstructured":"Christofi, T. & Zaravinos, A. RNA editing in the forefront of epitranscriptomics and human health. J. Transl. Med. 17, 319 (2019).","journal-title":"J. Transl. Med."},{"key":"429_CR17","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1101\/gr.134957.111","volume":"22","author":"E Park","year":"2012","unstructured":"Park, E., Williams, B., Wold, B. J. & Mortazavi, A. RNA editing in the human ENCODE RNA-seq data. Genome Res. 22, 1626\u20131633 (2012).","journal-title":"Genome Res."},{"key":"429_CR18","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/nbt.2122","volume":"30","author":"Z Peng","year":"2012","unstructured":"Peng, Z. et al. Comprehensive analysis of RNA-Seq data reveals extensive RNA editing in a human transcriptome. Nat. Biotechnol. 30, 253\u2013260 (2012).","journal-title":"Nat. Biotechnol."},{"key":"429_CR19","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1101\/gr.164749.113","volume":"24","author":"L Bazak","year":"2014","unstructured":"Bazak, L. et al. A-to-I RNA editing occurs at over a hundred million genomic sites, located in a majority of human genes. Genome Res. 24, 365\u2013376 (2014).","journal-title":"Genome Res."},{"key":"429_CR20","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nsmb1041","volume":"13","author":"W Yang","year":"2006","unstructured":"Yang, W. et al. Modulation of microRNA processing and expression through RNA editing by ADAR deaminases. Nat. Struct. Mol. Biol. 13, 13\u201321 (2006).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"429_CR21","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.tibs.2016.05.001","volume":"41","author":"JD Salter","year":"2016","unstructured":"Salter, J. D., Bennett, R. P. & Smith, H. C. The APOBEC Protein Family: United by Structure, Divergent in Function. Trends Biochem. Sci. 41, 578\u2013594 (2016).","journal-title":"Trends Biochem. Sci."},{"key":"429_CR22","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1126\/science.8511591","volume":"260","author":"B Teng","year":"1993","unstructured":"Teng, B., Burant, C. F. & Davidson, N. O. Molecular cloning of an apolipoprotein B messenger RNA editing protein. Science 260, 1816\u20131819 (1993).","journal-title":"Science"},{"key":"429_CR23","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/nsmb.1975","volume":"18","author":"BR Rosenberg","year":"2011","unstructured":"Rosenberg, B. R., Hamilton, C. E., Mwangi, M. M., Dewell, S. & Papavasiliou, F. N. Transcriptome-wide sequencing reveals numerous APOBEC1 mRNA-editing targets in transcript 3\u2019 UTRs. Nat. Struct. Mol. Biol. 18, 230\u2013236 (2011).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"429_CR24","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1080\/15476286.2016.1184387","volume":"14","author":"S Sharma","year":"2017","unstructured":"Sharma, S., Patnaik, S. K., Kemer, Z. & Baysal, B. E. Transient overexpression of exogenous APOBEC3A causes C-to-U RNA editing of thousands of genes. RNA Biol. 14, 603\u2013610 (2017).","journal-title":"RNA Biol."},{"key":"429_CR25","doi-asserted-by":"publisher","first-page":"3733","DOI":"10.1158\/0008-5472.CAN-17-0520","volume":"77","author":"BE Baysal","year":"2017","unstructured":"Baysal, B. E., Sharma, S., Hashemikhabir, S. & Janga, S. C. RNA editing in pathogenesis of cancer. Cancer Res. 77, 3733\u20133739 (2017).","journal-title":"Cancer Res."},{"key":"429_CR26","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1158\/2159-8290.CD-15-0344","volume":"5","author":"C Swanton","year":"2015","unstructured":"Swanton, C., McGranahan, N., Starrett, G. J. & Harris, R. S. APOBEC enzymes: mutagenic fuel for cancer evolution and heterogeneity. Cancer Discov. 5, 704\u2013712 (2015).","journal-title":"Cancer Discov."},{"key":"429_CR27","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.molcel.2017.03.013","volume":"66","author":"B Kim","year":"2017","unstructured":"Kim, B., Jeong, K. & Kim, V. N. Genome-wide mapping of DROSHA cleavage sites on primary MicroRNAs and noncanonical substrates. Mol. Cell 66, 258\u2013269 e255 (2017).","journal-title":"Mol. Cell"},{"key":"429_CR28","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.molcel.2018.11.005","volume":"73","author":"SC Kwon","year":"2019","unstructured":"Kwon, S. C. et al. Molecular basis for the single-nucleotide precision of primary microRNA processing. Mol. Cell 73, 505\u2013518 e505 (2019).","journal-title":"Mol. Cell"},{"key":"429_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1261\/rna.068692.118","volume":"25","author":"G Michlewski","year":"2019","unstructured":"Michlewski, G. & Caceres, J. F. Post-transcriptional control of miRNA biogenesis. RNA 25, 1\u201316 (2019).","journal-title":"RNA"},{"key":"429_CR30","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/j.cell.2012.09.042","volume":"151","author":"S Gu","year":"2012","unstructured":"Gu, S. et al. The loop position of shRNAs and pre-miRNAs is critical for the accuracy of dicer processing in vivo. Cell 151, 900\u2013911 (2012).","journal-title":"Cell"},{"key":"429_CR31","doi-asserted-by":"publisher","first-page":"3726","DOI":"10.1093\/nar\/gky043","volume":"46","author":"L Zhu","year":"2018","unstructured":"Zhu, L., Kandasamy, S. K. & Fukunaga, R. Dicer partner protein tunes the length of miRNAs using base-mismatch in the pre-miRNA stem. Nucleic Acids Res. 46, 3726\u20133741 (2018).","journal-title":"Nucleic Acids Res."},{"key":"429_CR32","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41580-018-0045-7","volume":"20","author":"LFR Gebert","year":"2019","unstructured":"Gebert, L. F. R. & MacRae, I. J. Regulation of microRNA function in animals. Nat. Rev. Mol. Cell Biol. 20, 21\u201337 (2019).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"429_CR33","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1093\/bioinformatics\/bty843","volume":"35","author":"X Bofill-De Ros","year":"2019","unstructured":"Bofill-De Ros, X. et al. QuagmiR: a cloud-based application for isomiR big data analytics. Bioinformatics 35, 1576\u20131578 (2019).","journal-title":"Bioinformatics"},{"key":"429_CR34","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/nrm.2016.132","volume":"18","author":"BS Zhao","year":"2017","unstructured":"Zhao, B. S., Roundtree, I. A. & He, C. Post-transcriptional gene regulation by mRNA modifications. Nat. Rev. Mol. Cell Biol. 18, 31\u201342 (2017).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"429_CR35","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/nchembio.1432","volume":"10","author":"J Liu","year":"2014","unstructured":"Liu, J. et al. A METTL3-METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation. Nat. Chem. Biol. 10, 93\u201395 (2014).","journal-title":"Nat. Chem. Biol."},{"key":"429_CR36","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.molcel.2016.05.041","volume":"63","author":"P Wang","year":"2016","unstructured":"Wang, P., Doxtader, K. A. & Nam, Y. Structural basis for cooperative function of Mettl3 and Mettl14 methyltransferases. Mol. Cell 63, 306\u2013317 (2016).","journal-title":"Mol. Cell"},{"key":"429_CR37","doi-asserted-by":"publisher","first-page":"33292","DOI":"10.1074\/jbc.M113.500397","volume":"288","author":"K Horiuchi","year":"2013","unstructured":"Horiuchi, K. et al. Identification of Wilms\u2019 tumor 1-associating protein complex and its role in alternative splicing and the cell cycle. J. Biol. Chem. 288, 33292\u201333302 (2013).","journal-title":"J. Biol. Chem."},{"key":"429_CR38","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.celrep.2014.05.048","volume":"8","author":"S Schwartz","year":"2014","unstructured":"Schwartz, S. et al. Perturbation of m6A writers reveals two distinct classes of mRNA methylation at internal and 5\u2019 sites. Cell Rep. 8, 284\u2013296 (2014).","journal-title":"Cell Rep."},{"key":"429_CR39","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/nature19342","volume":"537","author":"DP Patil","year":"2016","unstructured":"Patil, D. P. et al. m(6)A RNA methylation promotes XIST-mediated transcriptional repression. Nature 537, 369\u2013373 (2016).","journal-title":"Nature"},{"key":"429_CR40","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.cell.2017.05.003","volume":"169","author":"KE Pendleton","year":"2017","unstructured":"Pendleton, K. E. et al. The U6 snRNA m(6)A methyltransferase METTL16 regulates SAM synthetase intron retention. Cell 169, 824\u2013835 e814 (2017).","journal-title":"Cell"},{"key":"429_CR41","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.molcel.2012.10.015","volume":"49","author":"G Zheng","year":"2013","unstructured":"Zheng, G. et al. ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility. Mol. Cell 49, 18\u201329 (2013).","journal-title":"Mol. Cell"},{"key":"429_CR42","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/nrg3724","volume":"15","author":"Y Fu","year":"2014","unstructured":"Fu, Y., Dominissini, D., Rechavi, G. & He, C. Gene expression regulation mediated through reversible m(6)A RNA methylation. Nat. Rev. Genet. 15, 293\u2013306 (2014).","journal-title":"Nat. Rev. Genet."},{"key":"429_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-017-0129-x","volume":"9","author":"D Dai","year":"2018","unstructured":"Dai, D., Wang, H., Zhu, L., Jin, H. & Wang, X. N6-methyladenosine links RNA metabolism to cancer progression. Cell Death Dis. 9, 124 (2018).","journal-title":"Cell Death Dis."},{"key":"429_CR44","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nature11112","volume":"485","author":"D Dominissini","year":"2012","unstructured":"Dominissini, D. et al. Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq. Nature 485, 201\u2013206 (2012).","journal-title":"Nature"},{"key":"429_CR45","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.molcel.2019.07.005","volume":"76","author":"KI Zhou","year":"2019","unstructured":"Zhou, K. I. et al. Regulation of co-transcriptional pre-mRNA splicing by m(6)A through the low-complexity protein hnRNPG. Mol. Cell 76, 70\u201381 e79 (2019).","journal-title":"Mol. Cell"},{"key":"429_CR46","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/j.cell.2015.08.011","volume":"162","author":"CR Alarcon","year":"2015","unstructured":"Alarcon, C. R. et al. HNRNPA2B1 Is a mediator of m(6)A-dependent nuclear RNA processing events. Cell 162, 1299\u20131308 (2015).","journal-title":"Cell"},{"key":"429_CR47","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/nature14234","volume":"518","author":"N Liu","year":"2015","unstructured":"Liu, N. et al. N(6)-methyladenosine-dependent RNA structural switches regulate RNA-protein interactions. Nature 518, 560\u2013564 (2015).","journal-title":"Nature"},{"key":"429_CR48","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/nrm.2016.116","volume":"18","author":"B Tian","year":"2017","unstructured":"Tian, B. & Manley, J. L. Alternative polyadenylation of mRNA precursors. Nat. Rev. Mol. Cell Biol. 18, 18\u201330 (2017).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"429_CR49","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1261\/rna.2107305","volume":"11","author":"J Hu","year":"2005","unstructured":"Hu, J., Lutz, C. S., Wilusz, J. & Tian, B. Bioinformatic identification of candidate cis-regulatory elements involved in human mRNA polyadenylation. RNA 11, 1485\u20131493 (2005).","journal-title":"RNA"},{"key":"429_CR50","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1093\/nar\/gki158","volume":"33","author":"B Tian","year":"2005","unstructured":"Tian, B., Hu, J., Zhang, H. & Lutz, C. S. A large-scale analysis of mRNA polyadenylation of human and mouse genes. Nucleic Acids Res. 33, 201\u2013212 (2005).","journal-title":"Nucleic Acids Res."},{"key":"429_CR51","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1126\/science.1155390","volume":"320","author":"R Sandberg","year":"2008","unstructured":"Sandberg, R., Neilson, J. R., Sarma, A., Sharp, P. A. & Burge, C. B. Proliferating cells express mRNAs with shortened 3\u2019 untranslated regions and fewer microRNA target sites. Science 320, 1643\u20131647 (2008).","journal-title":"Science"},{"key":"429_CR52","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/nature14321","volume":"522","author":"BD Berkovits","year":"2015","unstructured":"Berkovits, B. D. & Mayr, C. Alternative 3\u2019 UTRs act as scaffolds to regulate membrane protein localization. Nature 522, 363\u2013367 (2015).","journal-title":"Nature"},{"key":"429_CR53","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/s41586-018-0465-8","volume":"561","author":"SH Lee","year":"2018","unstructured":"Lee, S. H. et al. Widespread intronic polyadenylation inactivates tumour suppressor genes in leukaemia. Nature 561, 127\u2013131 (2018).","journal-title":"Nature"},{"key":"429_CR54","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.ccell.2018.07.001","volume":"34","author":"A Kahles","year":"2018","unstructured":"Kahles, A. et al. Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients. Cancer Cell 34, 211\u2013224 e216 (2018).","journal-title":"Cancer Cell"},{"key":"429_CR55","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s00262-018-2284-z","volume":"68","author":"NB Hassounah","year":"2019","unstructured":"Hassounah, N. B. et al. Identification and characterization of an alternative cancer-derived PD-L1 splice variant. Cancer Immunol. Immunother. 68, 407\u2013420 (2019).","journal-title":"Cancer Immunol. Immunother."},{"key":"429_CR56","doi-asserted-by":"publisher","first-page":"207","DOI":"10.2174\/1567202613666160525115446","volume":"13","author":"CC Shen","year":"2016","unstructured":"Shen, C. C. et al. Two novel heparin-binding vascular endothelial growth factor splices, L-VEGF144 and L-VEGF138, are expressed in human glioblastoma cells. Curr. Neurovasc. Res. 13, 207\u2013218 (2016).","journal-title":"Curr. Neurovasc. Res."},{"key":"429_CR57","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1038\/sj.onc.1209253","volume":"25","author":"AM Hossini","year":"2006","unstructured":"Hossini, A. M., Geilen, C. C., Fecker, L. F., Daniel, P. T. & Eberle, J. A novel Bcl-x splice product, Bcl-xAK, triggers apoptosis in human melanoma cells without BH3 domain. Oncogene 25, 2160\u20132169 (2006).","journal-title":"Oncogene"},{"key":"429_CR58","doi-asserted-by":"publisher","first-page":"4123","DOI":"10.1158\/0008-5472.CAN-12-1343","volume":"73","author":"Y Zeng","year":"2013","unstructured":"Zeng, Y. et al. Stress-response protein RBM3 attenuates the stem-like properties of prostate cancer cells by interfering with CD44 variant splicing. Cancer Res. 73, 4123\u20134133 (2013).","journal-title":"Cancer Res."},{"key":"429_CR59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1001236","volume":"6","author":"JK Pickrell","year":"2010","unstructured":"Pickrell, J. K., Pai, A. A., Gilad, Y. & Pritchard, J. K. Noisy splicing drives mRNA isoform diversity in human cells. PLoS Genet. 6, e1001236 (2010).","journal-title":"PLoS Genet."},{"key":"429_CR60","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/nature10496","volume":"478","author":"K Yoshida","year":"2011","unstructured":"Yoshida, K. et al. Frequent pathway mutations of splicing machinery in myelodysplasia. Nature 478, 64\u201369 (2011).","journal-title":"Nature"},{"key":"429_CR61","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.cell.2014.01.051","volume":"156","author":"F Supek","year":"2014","unstructured":"Supek, F., Minana, B., Valcarcel, J., Gabaldon, T. & Lehner, B. Synonymous mutations frequently act as driver mutations in human cancers. Cell 156, 1324\u20131335 (2014).","journal-title":"Cell"},{"key":"429_CR62","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1182\/blood-2015-03-633537","volume":"126","author":"L Malcovati","year":"2015","unstructured":"Malcovati, L. et al. SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts. Blood 126, 233\u2013241 (2015).","journal-title":"Blood"},{"key":"429_CR63","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.ccell.2018.03.026","volume":"33","author":"X Peng","year":"2018","unstructured":"Peng, X. et al. A-to-I RNA editing contributes to proteomic diversity in cancer. Cancer Cell 33, 817\u2013828 e817 (2018).","journal-title":"Cancer Cell"},{"key":"429_CR64","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13000-017-0600-0","volume":"12","author":"Y Chen","year":"2017","unstructured":"Chen, Y., Wang, H., Lin, W. & Shuai, P. ADAR1 overexpression is associated with cervical cancer progression and angiogenesis. Diagn. Pathol. 12, 12 (2017).","journal-title":"Diagn. Pathol."},{"key":"429_CR65","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1182\/blood-2018-02-832576","volume":"132","author":"PJ Teoh","year":"2018","unstructured":"Teoh, P. J. et al. Aberrant hyperediting of the myeloma transcriptome by ADAR1 confers oncogenicity and is a marker of poor prognosis. Blood 132, 1304\u20131317 (2018).","journal-title":"Blood"},{"key":"429_CR66","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.stem.2016.05.004","volume":"19","author":"MA Zipeto","year":"2016","unstructured":"Zipeto, M. A. et al. ADAR1 activation drives leukemia stem cell self-renewal by impairing Let-7 biogenesis. Cell Stem Cell 19, 177\u2013191 (2016).","journal-title":"Cell Stem Cell"},{"key":"429_CR67","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.ccell.2015.08.013","volume":"28","author":"L Han","year":"2015","unstructured":"Han, L. et al. The genomic landscape and clinical relevance of A-to-I RNA editing in human cancers. Cancer Cell 28, 515\u2013528 (2015).","journal-title":"Cancer Cell"},{"key":"429_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10715","volume":"7","author":"K Gumireddy","year":"2016","unstructured":"Gumireddy, K. et al. The mRNA-edited form of GABRA3 suppresses GABRA3-mediated Akt activation and breast cancer metastasis. Nat. Commun. 7, 10715 (2016).","journal-title":"Nat. Commun."},{"key":"429_CR69","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1053\/j.gastro.2016.06.043","volume":"151","author":"TH Chan","year":"2016","unstructured":"Chan, T. H. et al. ADAR-mediated RNA editing predicts progression and prognosis of gastric cancer. Gastroenterology 151, 637\u2013650 e610 (2016).","journal-title":"Gastroenterology"},{"key":"429_CR70","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1084\/jem.20132209","volume":"211","author":"SW Han","year":"2014","unstructured":"Han, S. W. et al. RNA editing in RHOQ promotes invasion potential in colorectal cancer. J. Exp. Med. 211, 613\u2013621 (2014).","journal-title":"J. Exp. Med."},{"key":"429_CR71","doi-asserted-by":"publisher","first-page":"E4631","DOI":"10.1073\/pnas.1619960114","volume":"114","author":"L Fu","year":"2017","unstructured":"Fu, L. et al. RNA editing of SLC22A3 drives early tumor invasion and metastasis in familial esophageal cancer. Proc. Natl Acad. Sci. USA 114, E4631\u2013E4640 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"429_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/srep23226","volume":"6","author":"L Zhang","year":"2016","unstructured":"Zhang, L., Yang, C. S., Varelas, X. & Monti, S. Altered RNA editing in 3\u2019 UTR perturbs microRNA-mediated regulation of oncogenes and tumor-suppressors. Sci. Rep. 6, 23226 (2016).","journal-title":"Sci. Rep."},{"key":"429_CR73","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1126\/science.1138050","volume":"315","author":"Y Kawahara","year":"2007","unstructured":"Kawahara, Y. et al. Redirection of silencing targets by adenosine-to-inosine editing of miRNAs. Science 315, 1137\u20131140 (2007).","journal-title":"Science"},{"key":"429_CR74","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/ncb3110","volume":"17","author":"E Shoshan","year":"2015","unstructured":"Shoshan, E. et al. Reduced adenosine-to-inosine miR-455-5p editing promotes melanoma growth and metastasis. Nat. Cell Biol. 17, 311\u2013321 (2015).","journal-title":"Nat. Cell Biol."},{"key":"429_CR75","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0575-z","volume":"16","author":"S Tomaselli","year":"2015","unstructured":"Tomaselli, S. et al. Modulation of microRNA editing, expression and processing by ADAR2 deaminase in glioblastoma. Genome Biol. 16, 5 (2015).","journal-title":"Genome Biol."},{"key":"429_CR76","doi-asserted-by":"publisher","first-page":"4059","DOI":"10.1172\/JCI62925","volume":"122","author":"Y Choudhury","year":"2012","unstructured":"Choudhury, Y. et al. Attenuated adenosine-to-inosine editing of microRNA-376a* promotes invasiveness of glioblastoma cells. J. Clin. Invest. 122, 4059\u20134076 (2012).","journal-title":"J. Clin. Invest."},{"key":"429_CR77","doi-asserted-by":"publisher","first-page":"4422","DOI":"10.1038\/onc.2016.27","volume":"35","author":"C Anadon","year":"2016","unstructured":"Anadon, C. et al. Gene amplification-associated overexpression of the RNA editing enzyme ADAR1 enhances human lung tumorigenesis. Oncogene 35, 4422 (2016).","journal-title":"Oncogene"},{"key":"429_CR78","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1101\/gr.219741.116","volume":"27","author":"Y Wang","year":"2017","unstructured":"Wang, Y. et al. Systematic characterization of A-to-I RNA editing hotspots in microRNAs across human cancers. Genome Res. 27, 1112\u20131125 (2017).","journal-title":"Genome Res."},{"key":"429_CR79","doi-asserted-by":"publisher","first-page":"9424","DOI":"10.1093\/nar\/gku656","volume":"42","author":"GC Tan","year":"2014","unstructured":"Tan, G. C. et al. 5\u2019 isomiR variation is of functional and evolutionary importance. Nucleic Acids Res. 42, 9424\u20139435 (2014).","journal-title":"Nucleic Acids Res."},{"key":"429_CR80","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.celrep.2018.12.054","volume":"26","author":"X Bofill-De Ros","year":"2019","unstructured":"Bofill-De Ros, X. et al. Structural differences between Pri-miRNA paralogs promote alternative drosha cleavage and expand target repertoires. Cell Rep. 26, 447\u2013459 e444 (2019).","journal-title":"Cell Rep."},{"key":"429_CR81","doi-asserted-by":"crossref","unstructured":"Bofill-De Ros, X., Yang, A. & Gu, S. IsomiRs: Expanding the miRNA repression toolbox beyond the seed. Biochim. Biophys. Acta Gene Regul. Mech. 1863, 194373, (2019).","DOI":"10.1016\/j.bbagrm.2019.03.005"},{"key":"429_CR82","doi-asserted-by":"publisher","first-page":"9158","DOI":"10.1093\/nar\/gkv922","volume":"43","author":"AG Telonis","year":"2015","unstructured":"Telonis, A. G., Loher, P., Jing, Y., Londin, E. & Rigoutsos, I. Beyond the one-locus-one-miRNA paradigm: microRNA isoforms enable deeper insights into breast cancer heterogeneity. Nucleic Acids Res. 43, 9158\u20139175 (2015).","journal-title":"Nucleic Acids Res."},{"key":"429_CR83","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1038\/ncb1931","volume":"11","author":"MR Jones","year":"2009","unstructured":"Jones, M. R. et al. Zcchc11-dependent uridylation of microRNA directs cytokine expression. Nat. Cell Biol. 11, 1157\u20131163 (2009).","journal-title":"Nat. Cell Biol."},{"key":"429_CR84","doi-asserted-by":"publisher","first-page":"6211","DOI":"10.1038\/s41388-019-0869-4","volume":"38","author":"NH Green","year":"2019","unstructured":"Green, N. H. et al. MTHFD2 links RNA methylation to metabolic reprogramming in renal cell carcinoma. Oncogene 38, 6211\u20136225 (2019).","journal-title":"Oncogene"},{"key":"429_CR85","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10669-0","volume":"10","author":"S Yang","year":"2019","unstructured":"Yang, S. et al. m(6)A mRNA demethylase FTO regulates melanoma tumorigenicity and response to anti-PD-1 blockade. Nat. Commun. 10, 2782 (2019).","journal-title":"Nat. Commun."},{"key":"429_CR86","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.molcel.2016.03.021","volume":"62","author":"S Lin","year":"2016","unstructured":"Lin, S., Choe, J., Du, P., Triboulet, R. & Gregory, R. I. The m(6)A methyltransferase METTL3 promotes translation in human cancer cells. Mol. Cell 62, 335\u2013345 (2016).","journal-title":"Mol. Cell"},{"key":"429_CR87","doi-asserted-by":"publisher","first-page":"E2047","DOI":"10.1073\/pnas.1521518113","volume":"113","author":"C Zhang","year":"2016","unstructured":"Zhang, C. et al. Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m(6)A-demethylation of NANOG mRNA. Proc. Natl Acad. Sci. USA 113, E2047\u2013E2056 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"429_CR88","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ccell.2016.11.017","volume":"31","author":"Z Li","year":"2017","unstructured":"Li, Z. et al. FTO plays an oncogenic role in acute myeloid leukemia as a N(6)-methyladenosine RNA demethylase. Cancer Cell 31, 127\u2013141 (2017).","journal-title":"Cancer Cell"},{"key":"429_CR89","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.ccell.2017.02.013","volume":"31","author":"S Zhang","year":"2017","unstructured":"Zhang, S. et al. m(6)A demethylase ALKBH5 maintains tumorigenicity of glioblastoma stem-like cells by sustaining FOXM1 expression and cell proliferation program. Cancer Cell 31, 591\u2013606 e596 (2017).","journal-title":"Cancer Cell"},{"key":"429_CR90","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1016\/j.celrep.2017.02.059","volume":"18","author":"Q Cui","year":"2017","unstructured":"Cui, Q. et al. m(6)A RNA methylation regulates the self-renewal and tumorigenesis of glioblastoma stem cells. Cell Rep. 18, 2622\u20132634 (2017).","journal-title":"Cell Rep."},{"key":"429_CR91","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.cell.2009.06.016","volume":"138","author":"C Mayr","year":"2009","unstructured":"Mayr, C. & Bartel, D. P. Widespread shortening of 3\u2019UTRs by alternative cleavage and polyadenylation activates oncogenes in cancer cells. Cell 138, 673\u2013684 (2009).","journal-title":"Cell"},{"key":"429_CR92","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/s41588-018-0118-8","volume":"50","author":"HJ Park","year":"2018","unstructured":"Park, H. J. et al. 3\u2019 UTR shortening represses tumor-suppressor genes in trans by disrupting ceRNA crosstalk. Nat. Genet. 50, 783\u2013789 (2018).","journal-title":"Nat. Genet."},{"key":"429_CR93","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms6274","volume":"5","author":"Z Xia","year":"2014","unstructured":"Xia, Z. et al. Dynamic analyses of alternative polyadenylation from RNA-seq reveal a 3\u2019-UTR landscape across seven tumour types. Nat. Commun. 5, 5274 (2014).","journal-title":"Nat. Commun."},{"key":"429_CR94","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04112-z","volume":"9","author":"I Singh","year":"2018","unstructured":"Singh, I. et al. Widespread intronic polyadenylation diversifies immune cell transcriptomes. Nat. Commun. 9, 1716 (2018).","journal-title":"Nat. Commun."},{"key":"429_CR95","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00578-5","volume":"8","author":"S Mroczek","year":"2017","unstructured":"Mroczek, S. et al. The non-canonical poly(A) polymerase FAM46C acts as an onco-suppressor in multiple myeloma. Nat. Commun. 8, 619 (2017).","journal-title":"Nat. Commun."},{"key":"429_CR96","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1002\/hep.29606","volume":"67","author":"Q Shen","year":"2018","unstructured":"Shen, Q. et al. Barrier to autointegration factor 1, procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3, and splicing factor 3b subunit 4 as early-stage cancer decision markers and drivers of hepatocellular carcinoma. Hepatology 67, 1360\u20131377 (2018).","journal-title":"Hepatology"},{"key":"429_CR97","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/nm.3043","volume":"19","author":"L Chen","year":"2013","unstructured":"Chen, L. et al. Recoding RNA editing of AZIN1 predisposes to hepatocellular carcinoma. Nat. Med. 19, 209\u2013216 (2013).","journal-title":"Nat. Med."},{"key":"429_CR98","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1002\/hep.28885","volume":"65","author":"JZ Ma","year":"2017","unstructured":"Ma, J. Z. et al. METTL14 suppresses the metastatic potential of hepatocellular carcinoma by modulating N(6) -methyladenosine-dependent primary MicroRNA processing. Hepatology 65, 529\u2013543 (2017).","journal-title":"Hepatology"},{"key":"429_CR99","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1002\/hep.29683","volume":"67","author":"M Chen","year":"2018","unstructured":"Chen, M. et al. RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2. Hepatology 67, 2254\u20132270 (2018).","journal-title":"Hepatology"},{"key":"429_CR100","doi-asserted-by":"publisher","first-page":"4887","DOI":"10.1038\/s41388-018-0280-6","volume":"37","author":"S Tan","year":"2018","unstructured":"Tan, S. et al. NUDT21 negatively regulates PSMB2 and CXXC5 by alternative polyadenylation and contributes to hepatocellular carcinoma suppression. Oncogene 37, 4887\u20134900 (2018).","journal-title":"Oncogene"},{"key":"429_CR101","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1124\/pr.115.011239","volume":"69","author":"DO Bates","year":"2017","unstructured":"Bates, D. O., Morris, J. C., Oltean, S. & Donaldson, L. F. Pharmacology of modulators of alternative splicing. Pharm. Rev. 69, 63\u201379 (2017).","journal-title":"Pharm. Rev."}],"container-title":["Experimental &amp; Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s12276-020-0429-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-020-0429-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-020-0429-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,17]],"date-time":"2022-04-17T14:03:54Z","timestamp":1650204234000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s12276-020-0429-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":101,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["429"],"URL":"https:\/\/doi.org\/10.1038\/s12276-020-0429-6","relation":{},"ISSN":["1226-3613","2092-6413"],"issn-type":[{"value":"1226-3613","type":"print"},{"value":"2092-6413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"29 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}